Total Funding
51
37
Total FundingPost-IPO Debt raised
Growth Score
-5 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
202061
Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases.
- Johannes Bacher: Co-Founder and COO
- Andreas Boos: Co-Founder and CTO
About the Company
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.
Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application.
However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
